Katherine Natalia Natalia Aguirre Guataqui

Ms. Katherine Natalia Natalia Aguirre Guataqui

Universidad Nacional de Colombia, Bogotá, Colombia
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
Andres Ceballos-GarzonAndres Ceballos-Garzon
Andres Ceballos-Garzon
ECErika Cabrera
Erika Cabrera
GCGloria Cecilia Cortes-Fraile
Gloria Cecilia Cortes-Fraile
ALAura León
Aura León
KGKatherine Natalia Natalia Aguirre Guataqui
Katherine Natalia Natalia Aguirre Guataqui
Claudia Marcela Marcela Parra-GiraldoClaudia Marcela Marcela Parra-Giraldo
Claudia Marcela Marcela Parra-Giraldo
Bloodstream infections (BSIs) are a major cause of mortality in hospitalized patients. Rapid diagnosis is crucial because any delay in the antimicrobial treatment is associated with an increase in adverse patient outcomes. The application of matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) technology directly to blood cultures permits earlier identification of BSIs and facilitates treatment management. A total of 470 positive blood cultures from patient samples were analyzed using Standard Aerobic/F and Anaerobic/F blood culture media. Isolates were identified using conventional identification methods and by the direct method using the MALDI-TOF MS system. In 470 blood cultures, the direct method showed good identification results (420/470, 89%); specifically, accurate species and genus identification in 283/470 (60%), and only correct genus identification in 137/470 (29%). The direct protocol had better performance for Gram-negative compared to Gram-positive bacteria (97% vs 76%) and was unable to identify the positive blood cultures for both yeasts and some bacteria, mostly Gram-positive (50/470). The protocol used here gave good and reliable results, being available up to 24 h earlier, while also leading to better use of MALDI-TOF.

5 November 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
KGKatherine Natalia Natalia Aguirre Guataqui
Katherine Natalia Natalia Aguirre Guataqui
MMMateo Márquez-Torres
Mateo Márquez-Torres
HPHéctor Pineda-Castañeda
Héctor Pineda-Castañeda
Yerly Vargas-CasanovaYerly Vargas-Casanova
Yerly Vargas-Casanova
Andres Ceballos-GarzonAndres Ceballos-Garzon
Andres Ceballos-Garzon
Claudia Marcela Marcela Parra-GiraldoClaudia Marcela Marcela Parra-Giraldo
Claudia Marcela Marcela Parra-Giraldo
Antimicrobial peptides (AMPs) are considered to be a valuable source for the identification and/or design of promising candidates for the development of antifungal treatments, since they have advantages such as lower tendency to induce resistance, ease of production, and high purity and safety. Bovine lactoferricin (LfcinB) and Buforin II (BFII) are AMPs to which great antimicrobial potential has been attributed. The minimum motives with antimicrobial activity derived from LfcinB and BFII are RRWQWR and RLLR, respectively. Nine chimeras containing the minimum motives of both peptides were synthesized and their antifungal activity against fluconazole (FLC)-sensitive and resistant C. albicans, C. glabrata, and C. auris strains was evaluated. The results showed that peptides C9: (RRWQWR)2K-Ahx-RLLRRRLLR and C6: KKWQWK-Ahx-RLLRRLLR exhibited the greatest antifungal activity against two strains of C. albicans, a FLC-sensitive reference strain and a FLC-resistant clinical isolate; no medically significant results were observed with the other chimeras evaluated (MIC ~200 μg/mL). The chimera C6 was also active against sensitive and resistant strains of C. glabrata and C. auris. The combination of branched polyvalent chimeras together with FLC showed a synergistic effect against C. albicans. In addition to exhibiting antifungal activity against reference strains and clinical isolates of Candida spp., they also showed antibacterial activity against both Gram-positive and Gram-negative bacteria, suggesting that these chimeras exhibit a broad antimicrobial spectrum and can be considered to be promising molecules for therapeutic applications.

6 December 2025 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
JLJuan Javier Lopez-Rivera
Juan Javier Lopez-Rivera
NHNatalia Hernández-Bocanegra
Natalia Hernández-Bocanegra
KGKatherine Natalia Natalia Aguirre Guataqui
Katherine Natalia Natalia Aguirre Guataqui
MCMaría Paula Rodríguez Calderón
María Paula Rodríguez Calderón
LRLaura Rios
Laura Rios
MIMario Isaza-Ruget
Mario Isaza-Ruget
Considerable fraction of global cancer cases stem from hereditary cancer predisposition syndromes (HCSs). The identification of genetic variants linked to HCSs is crucial for prompt treatment of both patients and their families. This study aimed to assess the diagnostic performance of multigene panels in detecting variants linked to hereditary cancer predisposition in a cohort of 8165 individuals from Colombia. We analyzed 8165 individuals in Colombia (2018–2024), with and without personal or family cancer history, using NGS hereditary cancer panels. Variant interpretation (P, LP, VUS) was performed with SOPHiA DDM and Varsome Clinical, following ACMG guidelines and ClinGen Hereditary Cancer Group criteria. 61.8% (n = 5049) of patients were referred from Bogotá and 38.10% (n = 3116) from other cities in Colombia. It was not possible to distinguish between ethnic groups. The age range of patients was 0–97 (mean = 55 years; SD = 12.1), 86% (n = 7024) were female and 14% (n = 1142) male. 409 P/LP variants were identified in high-penetrance genes such as BRCA1/2, in 946 individuals, resulting in an overall diagnostic yield of 9.82%. Among the most important findings were increased diagnostic yields in ovarian and colorectal cancer, as well as in unaffected individuals with a family history of cancer. Finally, 38 novel variants and recurrent alterations in 27 HCS-related genes reinforce the need to prioritize these biomarkers in diagnostic evaluations. This study provides insights into the performance of genetic panels for detecting HCS-associated variants in the largest Latin American cohort evaluated to date. These findings demonstrate that robust panel-based testing strategies enable the systematic detection of clinically relevant signs that would not be captured through phenotype-driven approaches alone. BRCA1 and BRCA2 were the most frequently altered high-penetrance genes, with higher diagnostic yields in breast, ovarian, and colorectal cancers, as well as in unaffected individuals with a family history. Fundación Universitaria Sanitas.